ClinVar Miner

Submissions for variant NM_033380.3(COL4A5):c.2965_2982del (p.Asp989_Gly994del)

dbSNP: rs104886374
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Gharavi Laboratory, Columbia University RCV000681846 SCV000809323 likely pathogenic not provided 2018-09-16 criteria provided, single submitter research
Invitae RCV000681846 SCV001407268 pathogenic not provided 2021-10-10 criteria provided, single submitter clinical testing This variant disrupts the triple helix domain of COL4A5. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL4A5, missense variants at these glycine residues are significantly enriched in individuals with disease (PMID: 23720012, 27627812) compared to the general population (ExAC). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 24580). This variant is also known as 3161-3178del del987-992. This variant has been observed in individuals with clinical features of Alport syndrome (PMID: 10094548; Invitae). This variant is not present in population databases (ExAC no frequency). This variant, c.2965_2982del, results in the deletion of 6 amino acid(s) of the COL4A5 protein (p.Asp989_Gly994del), but otherwise preserves the integrity of the reading frame.
Division Of Personalized Genomic Medicine, Columbia University Irving Medical Center RCV002512053 SCV002822968 likely pathogenic X-linked Alport syndrome 2019-10-10 criteria provided, single submitter clinical testing The p.Asp989_Gly994del variant in the COL4A5 gene is a hemizygous in-frame deletion variant, which results in the removal of six amino acids in coding exon 34 of the COL4A5 gene (51 coding exons in total; NP_000486.1) and maps to the triple-helical region of the protein. This variant has not been observed in the Genome Aggregation Database (gnomAD), indicating it is not a common benign variant in the populations represented in this database. This variant has been reported in in a hemizygous male with end stage renal failure, characteristic basement membrane changes and a positive family history (PMID: 10094548). In ClinVar, this in-frame deletion overlaps with multiple Pathogenic/ Likely Pathogenic variants. Based on the evidence presented, this variant is classified as Likely Pathogenic.
CeGaT Center for Human Genetics Tuebingen RCV000681846 SCV004702310 pathogenic not provided 2024-01-01 criteria provided, single submitter clinical testing COL4A5: PM1:Strong, PM2, PM4, PS4:Moderate, PP4

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.